Montag, 23. Oktober 2017
Benutzername
Passwort
Registrieren
Passwort vergessen?

Home
e-journal
Der Aktuelle Fall
CME online
News
Gesundheitspolitik
Fachgesellschaften
Therapiealgorithmen
Videos
Veranstaltungen
Broschüren


Suche
Archiv
Buchbestellung
Newsletter
Probe-Abo
Impressum


journalmed.de


Anzeige:
 
 
Anzeige:
 
 

JOURNAL ONKOLOGIE – NEWS
Zurück
Zurück
E-Mail
Email
Drucken
Drucken
Zum Bewerten bitte anmelden!
31. Mai 2017

Der ASCO 2017 startet diese Woche

Vom 2. bis 6. Juni 2017 findet wieder das Jahrestreffen der ASCO (American Society of Clinical Oncology) in Chicago, Illinois, USA, statt. Erwartet werden über 30.000 Onkologen/ onkologisch Tätige aus aller Welt. Hier einige interessante abstracts mit Zeit und Ort der Präsentation.
Anzeige:
 
 
Web-based stress management for newly diagnosed cancer patients (STREAM): A randomized, wait-list controlled intervention study
Sub-category:
Psychosocial Research
Type: Oral Abstract Session
Time: Friday June 2, 3:00 PM to 6:00 PM
Location: S102

Viviane Hess, Astrid Grossert, Judith Alder et al. J Clin Oncol 35, 2017 (suppl; abstr LBA10002), http://abstracts.asco.org/199/AbstView_199_187932.html

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2 positive resectable esophagogastric adenocarcinoma: Petrarca—A phase II trial of the German AIO
Sub-category:
Esophageal or Gastric Cancer
Type: Poster Session
Time: Saturday June 3, 8:00 AM to 11:30 AM
Location: Hall A

Ralf Hofheinz, Gerrit zur Hausen, Kersten Borchert et al. J Clin Oncol 35, 2017 (suppl; abstr TPS4133), http://abstracts.asco.org/199/AbstView_199_188860.html


Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).
Session: Genitourinary (Prostate) Cancer
Time: Saturday June 3, 1:15 PM to 4:15 PM
Location: Hall B1

Nicholas D. James, Johann S. De Bono, Melissa Ruth Spears et al. J Clin Oncol 35, 2017 (suppl; abstr LBA5003), http://abstracts.asco.org/199/AbstView_199_186716.html


Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration
Session: Plenary Session Including the Science of Oncology Award and Lecture
Time: Sunday June 4, 1:00 PM to 4:00 PM
Location: Hall B1

Qian Shi, Alberto F. Sobrero, Anthony Frank Shields et al. J Clin Oncol 35, 2017 (suppl; abstr LBA1), http://abstracts.asco.org/199/AbstView_199_188616.html


Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
Session: Plenary Session Including the Science of Oncology Award and Lecture
Time: Sunday June 4, 1:00 PM to 4:00 PM
Location: Hall B1

Ethan M. Basch, Allison Mary Deal, Amylou C. Dueck et al. J Clin Oncol 35, 2017 (suppl; abstr LBA2), http://abstracts.asco.org/199/AbstView_199_194565.html


LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer
Session: Plenary Session Including the Science of Oncology Award and Lecture
Time: Sunday June 4, 1:00 PM to 4:00 PM
Location: Hall B1

Karim Fizazi, Namphuong Tran, Luis Enrique Fein et al. J Clin Oncol 35, 2017 (suppl; abstr LBA3), http://abstracts.asco.org/199/AbstView_199_181729.html


OlympiAD: Phase III trial of olaparib monotherapy versus chemotherapy for patients (pts) with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm)
Session: Plenary Session Including the Science of Oncology Award and Lecture
Time: Sunday June 4, 1:00 PM to 4:00 PM
Location: Hall B1

Mark E. Robson, Seock-Ah Im, Elżbieta Senkus et al. J Clin Oncol 35, 2017 (suppl; abstr LBA4), http://abstracts.asco.org/199/AbstView_199_186720.html


Alle ASCO-Abstracts unter: http://abstracts.asco.org/199/CatView_199_B.html

Mehr zum Kongress finden Sie hier.
ASCO 2017
 
Zurück
Zurück
E-Mail
Email
Drucken
Drucken
Zum Bewerten bitte anmelden!



Anzeige:
Zur Fachinformation
 
Anzeige:
 
 
 
 
Themen
CUP
CML
NET
Nutzen Sie auch die Inhalte von journalmed.de, um sich zu Informieren.
Mediadaten
Hilfe
Copyright © 2014 rs media GmbH. All rights reserved.
Kontakt
Datenschutz
AGB
Fakten über Krebs